Direct-acting antiviral agents in lymphoproliferative disorders: more complex than expected

Br J Haematol. 2020 Dec;191(5):661-662. doi: 10.1111/bjh.17037. Epub 2020 Aug 18.

Authors

Luca Arcaini^{1

2}, Raffaele Bruno^{3

4}

Affiliations

¹ Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
² Department of Molecular Medicine, University of Pavia, Pavia, Italy.
³ Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁴ Department of Medical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.

PMID: 32808671
DOI: 10.1111/bjh.17037

No abstract available

Keywords: antiviral agents; hepatitis C virus; lymphoproliferative disorders.

Publication types

Comment

MeSH terms

Antiviral Agents / therapeutic use
Cryoglobulinemia*
Hepacivirus
Hepatitis C*
Hepatitis C, Chronic* / drug therapy
Humans
Lymphoproliferative Disorders* / drug therapy

Substances

Antiviral Agents